DNAH5 and hepatocellular carcinoma: In the present study, with the help of The Cancer Genome Atlas (TCGA) and the International Cancer Genome Consortium (ICGC) databases, we identified and validated an immunity-related mutant gene—DNAH5—that has a significant correlation with the biological function of immune cells and the prognosis of HCC in patients and may be a potential immunotherapy target for HCC.